A genus in the family FILOVIRIDAE consisting of one species (Lake Victoria marburgvirus) with several strains. The genus shows no antigenic cross-reactivity with EBOLAVIRUS.
An RNA virus infection of rhesus, vervet, and squirrel monkeys transmissible to man.
A family of RNA viruses, of the order MONONEGAVIRALES, containing filamentous virions. Although they resemble RHABDOVIRIDAE in possessing helical nucleocapsids, Filoviridae differ in the length and degree of branching in their virions. There are two genera: EBOLAVIRUS and MARBURGVIRUS.
A genus in the family FILOVIRIDAE consisting of several distinct species of Ebolavirus, each containing separate strains. These viruses cause outbreaks of a contagious, hemorrhagic disease (HEMORRHAGIC FEVER, EBOLA) in humans, usually with high mortality.
A highly fatal, acute hemorrhagic fever, clinically very similar to MARBURG VIRUS DISEASE, caused by EBOLAVIRUS, first occurring in the Sudan and adjacent northwestern (what was then) Zaire.

The nucleoprotein of Marburg virus is target for multiple cellular kinases. (1/182)

The nucleoprotein (NP) of Marburg virus is phosphorylated at serine and threonine residues in a ratio of 85:15, regardless of whether the protein is isolated from virions or from eukaryotic expression systems. Phosphotyrosine is absent. Although many potential phosphorylation sites are located in the N-terminal half of NP, this part of the protein is not phosphorylated. Analyses of phosphorylation state and phosphoamino acid content of truncated NPs expressed in HeLa cells using the vaccinia virus T7 expression system led to the identification of seven phosphorylated regions (region I*, amino acids 404-432; II*, amino acids 446-472; III*, amino acids 484-511; IV*, amino acids 534-543; V*, amino acid 549; VI*, amino acids 599-604; and VII*, amino acid 619) with a minimum of seven phosphorylated amino acid residues located in the C-terminal half of NP. All phosphothreonine residues and consensus recognition sequences for protein kinase CKII are located in regions I*-V*. Regions VI* and VII* contain only phosphoserine with three of four serine residues in consensus recognition motifs for proline-directed protein kinases. Mutagenesis of proline-adjacent serine residues to alanine or aspartic acid did not influence the function of NP in a reconstituted transcription/replication system; thus it is concluded that serine phosphorylation in the most C-terminal part of NP is not a regulatory factor in viral RNA synthesis.  (+info)

Proteolytic processing of Marburg virus glycoprotein. (2/182)

Processing of the transmembrane glycoprotein (GP) of Marburg virus involved the conversion of an endo H-sensitive, ER-specific form into an endo H-resistant, Golgi-specific precursor that was cleaved into GP(1) and GP(2). Cleavage was mediated by furin or another subtilisin-like endoprotease with similar substrate specificity as indicated by mutational analysis of the cleavage site and inhibition using peptidyl chloromethylketones. Mature GP consisted of disulfide-linked GP(1) and GP(2) subunits.  (+info)

Ultrastructural organization of recombinant Marburg virus nucleoprotein: comparison with Marburg virus inclusions. (3/182)

HeLa cells expressing the recombinant Marburg virus (MBGV) nucleoprotein (NP) have been studied by immunoelectron microscopy. It was found that MBGV NPs assembled into large aggregates which were in close association with membranes of the rough endoplasmic reticulum. Further analysis of these aggregates revealed that NPs formed tubule-like structures which were arranged in a hexagonal pattern. A similar pattern of preformed nucleocapsids was detected in intracellular inclusions induced by MBGV infection. Our data indicated that MBGV NP is able to form nucleocapsid-like structures in the absence of the authentic viral genome and other nucleocapsid-associated proteins.  (+info)

Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. (4/182)

Since the Marburg (MBG) and Ebola (EBO) viruses have sequence homology and cause similar diseases, we hypothesized that they associate with target cells by similar mechanisms. Pseudotype viruses prepared with a luciferase-containing human immunodeficiency virus type 1 backbone and packaged by the MBG virus or the Zaire subtype EBO virus glycoproteins (GP) mediated infection of a comparable wide range of mammalian cell types, and both were inhibited by ammonium chloride. In contrast, they exhibited differential sensitivities to treatment of target cells with tunicamycin, endoglycosidase H, or protease (pronase). Therefore, while they exhibit certain functional similarities, the MBG and EBO virus GP interact with target cells by distinct processes.  (+info)

Crystal structure of the matrix protein VP40 from Ebola virus. (5/182)

Ebola virus maturation occurs at the plasma membrane of infected cells and involves the clustering of the viral matrix protein VP40 at the assembly site as well as its interaction with the lipid bilayer. Here we report the X-ray crystal structure of VP40 from Ebola virus at 2.0 A resolution. The crystal structure reveals that Ebola virus VP40 is topologically distinct from all other known viral matrix proteins, consisting of two domains with unique folds, connected by a flexible linker. The C-terminal domain, which is absolutely required for membrane binding, contains large hydrophobic patches that may be involved in the interaction with lipid bilayers. Likewise, a highly basic region is shared between the two domains. The crystal structure reveals how the molecule may be able to switch from a monomeric conformation to a hexameric form, as observed in vitro. Its implications for the assembly process are discussed.  (+info)

Differential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. (6/182)

Human infection by Marburg (MBG) or Ebola (EBO) virus is associated with fatal haemorrhagic fevers. While these filoviruses may both incite disease as a result of explosive virus replication, we hypothesized that expression of individual viral gene products, such as the envelope glycoprotein (GP), may directly alter target cells and contribute to pathogenesis. We found that expression of EBO GP in 293T cells caused significant levels of cellular detachment in the absence of cell death or virus replication. This detachment was induced most potently by membrane-bound EBO GP, rather than the shed glycoprotein products (sGP or GP1), and was largely attributable to a domain within the extracellular region of GP2. Furthermore, detachment was blocked by the Ser/Thr kinase inhibitor 2-aminopurine, suggesting the importance of a phosphorylation-dependent signalling cascade in inducing detachment. Since MBG GP did not induce similar cellular detachment, MBG and EBO GP interact with target cells by distinct processes to elicit cellular dysregulation.  (+info)

Enzyme-linked immunosorbent assays for detection of antibodies to Ebola and Marburg viruses using recombinant nucleoproteins. (7/182)

The full-length nucleoprotein (NP) of Ebola virus (EBO) was expressed as a His-tagged recombinant protein (His-EBO-NP) by a baculovirus system. Carboxy-terminal halves of NPs of EBO and Marburg virus (MBG) were expressed as glutathione S-transferase-tagged recombinant proteins in an Escherichia coli system. The antigenic regions on the NPs of EBO and MBG were determined by both Western blotting and enzyme-linked immunosorbent assay (ELISA) to be located on the C-terminal halves. The C-terminal 110 and 102 amino acids of the NPs of EBO and MBG, respectively, possess strong antigenicity. The full-length NP of EBO was strongly expressed in insect cells upon infection with the recombinant baculovirus, while expression of the full-length NP of MBG was weak. We developed an immunoglobulin G (IgG) ELISA using His-EBO-NP and the C-terminal halves of the NPs of EBO and MBG as antigens. We evaluated the IgG ELISA for the ability to detect IgG antibodies to EBO and MBG, using human sera collected from EBO and MBG patients. The IgG ELISA with the recombinant NPs showed high sensitivity and specificity in detecting EBO and MBG antibodies. The results indicate that ELISA systems prepared with the recombinant NPs of EBO and MBG are valuable tools for the diagnosis of EBO and MBG infections and for seroepidemiological field studies.  (+info)

Sorting of Marburg virus surface protein and virus release take place at opposite surfaces of infected polarized epithelial cells. (8/182)

Marburg virus, a filovirus, causes severe hemorrhagic fever with hitherto poorly understood molecular pathogenesis. We have investigated here the vectorial transport of the surface protein GP of Marburg virus in polarized epithelial cells. To this end, we established an MDCKII cell line that was able to express GP permanently (MDCK-GP). The functional integrity of GP expressed in these cells was analyzed using vesicular stomatitis virus pseudotypes. Further experiments revealed that GP is transported in MDCK-GP cells mainly to the apical membrane and is released exclusively into the culture medium facing the apical membrane. When MDCKII cells were infected with Marburg virus, the majority of GP was also transported to the apical membrane, suggesting that the protein contains an autonomous apical transport signal. Release of infectious progeny virions, however, took place exclusively at the basolateral membrane of the cells. Thus, vectorial budding of Marburg virus is presumably determined by factors other than the surface protein.  (+info)

According to the World Health Organization (WHO), Marburgviruses are toxiviral hemorrhagic fever-causing agents that belong to the Filoviridae family, which also includes Ebolaviruses. These enveloped, non-segmented, negative-stranded RNA viruses cause a severe and often fatal illness in humans and non-human primates. The Marburg virus was initially discovered in 1967, after simultaneous outbreaks occurred in laboratories in Marburg and Frankfurt, Germany, and in Belgrade, Yugoslavia (now Serbia).

The virions of Marburgviruses are typically filamentous or U-shaped and measure approximately 80 nm in diameter. The genome consists of a single non-segmented, negative-sense RNA molecule that encodes seven structural proteins: nucleoprotein (NP), polymerase cofactor protein (VP35), matrix protein (VP40), glycoprotein (GP), transcription activator protein (VP30), RNA-dependent RNA polymerase (L), and a small hydrophobic protein (sVP24 or VP80).

Marburgviruses are primarily transmitted to humans through contact with the bodily fluids of infected animals, such as bats and non-human primates. Human-to-human transmission can occur via direct contact with infected individuals' blood, secretions, organs, or other bodily fluids, as well as through contaminated surfaces and materials.

The incubation period for Marburg virus disease (MVD) typically ranges from 2 to 21 days. Initial symptoms include fever, chills, headache, muscle aches, and general malaise. As the disease progresses, patients may develop severe watery diarrhea, abdominal pain, nausea, vomiting, and unexplained bleeding or bruising. In fatal cases, MVD can cause multi-organ failure, shock, and death, often within 7 to 14 days after symptom onset.

Currently, there are no approved vaccines or antiviral treatments specifically for Marburg virus infections. However, supportive care, such as fluid replacement, electrolyte management, and treatment of secondary infections, can help improve outcomes for MVD patients. Preventive measures, including the use of personal protective equipment (PPE) and proper infection control practices, are crucial to reducing the risk of transmission during outbreaks.

Marburg Virus Disease (MVD) is an acute and often fatal viral hemorrhagic fever illness caused by the Marburg virus, a member of the filovirus family. It's a highly infectious disease that can be transmitted from human to human through direct contact with infected bodily fluids, tissues, or indirectly through contaminated surfaces and materials.

The incubation period for MVD ranges from 2 to 21 days, after which symptoms such as fever, chills, headache, muscle aches, severe malaise, and progressive weakness appear. Around the fifth day of illness, a maculopapular rash may occur, followed by diarrhea, nausea, vomiting, abdominal pain, and non-bloody stools. In some cases, patients may develop severe bleeding disorders, shock, liver failure, and multi-organ dysfunction, which can lead to death in 24-48 hours.

Currently, there are no approved vaccines or antiviral treatments for MVD, but supportive care is crucial for managing the symptoms of the disease. Preventive measures such as avoiding contact with infected individuals and their bodily fluids, wearing protective clothing, and practicing good hygiene can help prevent the spread of the virus.

Filoviridae is a family of negative-sense, single-stranded RNA viruses that includes three genera: Ebolavirus, Marburgvirus, and Cuevavirus. These viruses are known to cause severe hemorrhagic fever in humans and nonhuman primates, with high fatality rates. The most well-known members of this family are Ebola virus and Marburg virus.

The virions of Filoviridae are filamentous, often having a "U," "6," or "hook" shape, and can be up to 14,000 nanometers in length. The genome of these viruses is non-segmented and contains seven genes that encode for structural proteins and enzymes necessary for replication.

Transmission of Filoviridae occurs through direct contact with infected bodily fluids or contaminated surfaces, and infection can result in a range of symptoms including fever, severe headache, muscle pain, weakness, fatigue, and hemorrhage. There are currently no approved vaccines or antiviral treatments for Filoviridae infections, although several are in development.

Ebolavirus is a genus of viruses in the family Filoviridae, order Mononegavirales. It is named after the Ebola River in the Democratic Republic of Congo (formerly Zaire), where the virus was first identified in 1976. There are six species of Ebolavirus, four of which are known to cause disease in humans: Zaire ebolavirus, Sudan ebolavirus, Bundibugyo ebolavirus, and Tai Forest ebolavirus (formerly Cote d'Ivoire ebolavirus). The fifth species, Reston ebolavirus, is known to cause disease in non-human primates and pigs, but not in humans. The sixth and most recently identified species, Bombali ebolavirus, has not been associated with any human or animal diseases.

Ebolaviruses are enveloped, negative-sense, single-stranded RNA viruses that cause a severe and often fatal hemorrhagic fever in humans and non-human primates. The virus is transmitted to people from wild animals and spreads in the human population through human-to-human transmission. Fruit bats of the Pteropodidae family are considered to be the natural host of Ebolavirus.

The symptoms of Ebolavirus disease (EVD) typically include fever, severe headache, muscle pain, weakness, fatigue, and sore throat, followed by vomiting, diarrhea, rash, impaired kidney and liver function, and in some cases, both internal and external bleeding. The case fatality rate of EVD is variable but has been historically high, ranging from 25% to 90% in past outbreaks depending on the species and the quality of medical care. There are no licensed specific treatments or vaccines available for EVD, although several promising candidates are currently under development.

Ebola Hemorrhagic Fever (EHF) is a severe, often fatal illness in humans. It is one of the five identified subtypes of the Ebolavirus. The virus is transmitted to people from wild animals and spreads in the human population through human-to-human transmission.

The early symptoms include sudden onset of fever, fatigue, muscle pain, headache and sore throat. This is followed by vomiting, diarrhea, rash, symptoms of impaired kidney and liver function, and in some cases, both internal and external bleeding.

Laboratory findings include low white blood cell and platelet counts and elevated liver enzymes.

The virus is introduced into the human population through close contact with the blood, secretions, organs or other bodily fluids of infected animals such as fruit bats, porcupines and non-human primates. Then it spreads in communities through human-to-human transmission via direct contact (through broken skin or mucous membranes) with the blood, secretions, organs or other bodily fluids of infected people, and with surfaces and materials contaminated with these fluids.

Healthcare workers have frequently been infected while treating patients with suspected or confirmed EVD due to a lack of adequate infection prevention and control measures.

There are currently no approved specific antiviral drugs or vaccines for Ebola. Several promising treatments and vaccine candidates are being evaluated.

Marburg virus disease (MVD) is caused by a group of viruses called marburgviruses and is a rare type of viral hemorrhagic fever ... Recommendations for Marburg virus disease (MVD) infection prevention and control precautions are the same as for Ebola Disease ... people should monitor their health for 21 days and seek medical care immediately if they develop symptoms of Marburg virus ...
The genus Marburgvirus is the taxonomic home of Marburg marburgvirus, whose members are the two known marburgviruses, Marburg ... The name Marburgvirus is derived from the city of Marburg in Hesse, West Germany (where Marburg virus was first discovered), ... A virus that fulfills the criteria for being a member of the family Filoviridae is a member of the genus Marburgvirus if its ... The genus Marburgvirus is a virological taxon included in the family Filoviridae, order Mononegavirales. The genus currently ...
Marburg virus disease in Uganda - http://www.who.int/csr/don/25-october-2017-marburg-uganda/en/ ...
Marburg virus disease is a rare but highly fatal viral hemorrhagic fever caused by two zoonotic viruses, Marburg virus and Ravn ... Marburg (Marburg Virus Disease) , Marburg (Marburg Virus Disease) , CDC. *Ebola and Marburg , Disease Directory , Travelers ... Marburg virus is spread through contact (through broken skin or mucous membranes) with the blood or other body fluids ( ... Marburg virus is not spread through airborne transmission.. There is currently no Food and Drug Administration (FDA)-approved ...
Marburg virus disease is a highly virulent disease that causes haemorrhagic fever, with a fatality ratio of up to 88%. It is in ... Illness caused by Marburg virus begins abruptly, with high fever, severe headache and severe malaise. Muscle aches and pains ... Human infection with Marburg virus disease initially results from prolonged exposure to mines or caves inhabited by Rousettus ... Based on further analysis of ongoing research, WHO recommends that male survivors of Marburg virus disease practise safer sex ...
... In-Depth Coverage 8 July 2022 - Preliminary findings of two ... Marburg virus cases have prompted Ghana to prepare for a potential outbreak of the disease. If confirmed, these would the first ...
CDC Asks Doctors To Look Out For Deadly Marburg Virus Cases * At Least 5 Dead As Hemorrhagic Marburg Virus Spreads To Second ... marburg virus outbreak. * CDC Issues Travel Advisory Over Ebola-Like Disease Outbreak * Its Just A Matter Of Time: ...
Marburg virus disease is a rare but highly fatal viral hemorrhagic fever caused by two zoonotic viruses, Marburg virus and Ravn ... Marburg (Marburg Virus Disease) , Marburg (Marburg Virus Disease) , CDC. *Ebola and Marburg , Disease Directory , Travelers ... Marburg virus is spread through contact (through broken skin or mucous membranes) with the blood or other body fluids ( ... Marburg virus is not spread through airborne transmission.. There is currently no Food and Drug Administration (FDA)-approved ...
Marburg virus was first identified in 1967, when 31 people became sick in Germany and Yugoslavia in an outbreak that was ... The potential for the Marburg virus to spread far and wide means we need to stop it in its tracks," Dr. Matshidiso Moeti, WHO ... Marburg virus causes symptoms similar to Ebola, beginning with fever and weakness and often leading to internal or external ... A patient with the rare, but highly infectious Marburg virus disease has died in Guinea, according to a World Health ...
Tekmira Reports Complete Marburg Virus Protection in Non-human Primate Studies Sep 26, 2013 ... showing that siRNAs formulated in its lipid nanoparticles could provide 100 percent post-exposure protection against Marburg virus ...
Marburg virus in Egyptian fruit bats. 9 Comments / By Vincent Racaniello / 5 August 2009 ... Marburg virus, the founding member of the Filoviridae, is an enveloped virus with a negative-strand RNA genome. Other members ... Antibodies to Marburg virus were also detected in bat sera, and infectious virus was recovered from 4 animals, all of which ... Marburg virus has been isolated from Egyptian fruit bats (Rousettus aegyptiacus) living in Kitaka Cave, Uganda, demonstrating ...
No drug has been approved to treat Ebola virus or Marburg virus. People diagnosed with Ebola virus or Marburg virus receive ... For most people, the risk of getting Ebola virus or Marburg virus is low. The risk increases if you:. *Travel to Africa. Youre ... Ebola virus and Marburg virus live in animal hosts. Humans can get the viruses from infected animals. After the initial ... Ebola virus and Marburg virus are difficult to diagnose because early signs and symptoms resemble those of other diseases, such ...
Tanzania identifies Marburg virus that killed five. 22nd Mar 2023 , Source: BBC. The virus is part of a group of viruses that ...
The Marburg virus is a top concern for public health officials who are worried about the next pandemic. It has the potential to ... And if the Marburg Virus starts getting loose in the western world we will be facing a scenario that is absolutely unthinkable. ... The new outbreak of the Marburg Virus is happening in Ghana. The two victims that have died so far did not know each other, and ... Illness caused by Marburg virus begins abruptly, with high fever, severe headache and severe malaise. Muscle aches and pains ...
The Marburg virus is a highly dangerous microbe which causes severe fever, often accompanied by bleeding and organ failure.. It ... Tanzania on Friday declared the end of a deadly outbreak of the Marburg virus, more than two months after it was first ... Marburg virus outbreak in E. Guinea claims nine lives, WHO says real toll is double ... Zanzibar officials say Saudi, UAE travelers not at risk of deadly Marburg virus ...
... Surveillance report 9 Feb 2021. ... Ebola and Marburg virus diseases - Annual Epidemiological Report for 2019 - EN - [PDF-240.02 KB] ... Ebola and Marburg virus disease. In: ECDC. Annual epidemiological report for 2019. Stockholm: ECDC; 2021. ... For 2019, no cases of Ebola virus disease or Marburg virus disease were reported in the EU/EEA. ...
The One Health Initiative is a movement to forge co-equal, all inclusive collaborations between physicians, osteopathic physicians, veterinarians, dentists, nurses, and other scientific-health and environmentally related disciplines.
What are Ebola and Marburg virus infections? Ebola and Marburg are rare viral infections Overview of Viral Infections A virus ... How can I prevent Ebola and Marburg virus infection? Several vaccines and antiviral drugs are being developed. An Ebola vaccine ... What causes Ebola and Marburg virus infection? Ebola and Marburg viruses usually infect animals living in Central and West ... Doctors suspect Ebola or Marburg virus if youre ill and youre in or have recently traveled to a place where people are ...
Compared with Marburg virus infection, Ebola is more likely to be fatal, averaging a 59% death rate. Recovery takes a long time ... Symptoms of Ebola and Marburg Virus Infections People develop the first symptoms about 2 to 20 days after exposure to the virus ... The Marburg virus can remain in semen for up to 7 weeks after men no longer have symptoms. ... Prevention of Ebola and Marburg Virus Infections Several vaccines and antiviral medications have been developed. A Zaire Ebola ...
Marburg virus: symptoms, how it spreads, and more.. Marburg virus isnt a new disease, by any means. According to USA Today, it ... Ghana experienced a Marburg virus outbreak last year.. In July 2022, Ghana experienced a Marburg virus outbreak as well. ... The #Marburg virus vaccine consortium (MARVAC) is meeting today to discuss the new Marburg virus disease outbreak in # ... After it was announced that Equatorial Guinea is facing a Marburg virus outbreak, many are wondering how the Marburg virus ...
Compared with Marburg virus infection, Ebola is more likely to be fatal, averaging a 59% death rate. Recovery takes a long time ... Symptoms of Ebola and Marburg Virus Infections People develop the first symptoms about 2 to 20 days after exposure to the virus ... The Marburg virus can remain in semen for up to 7 weeks after men no longer have symptoms. ... Prevention of Ebola and Marburg Virus Infections Several vaccines and antiviral medications have been developed. A Zaire Ebola ...
One theory is that the Marburg virus lives in a cave in Kenya, Kitum Cave in Mount Elgon National Park, a cave that is ... And in 2005 there was a very deadly high death rate Marburg virus outbreak in Angola Africa, which in particular is killing ... Revelation13.net: Ebola and Marburg Virus Diseases - The "Andromeda Strain"? - A New Age / Bible Prophecy / King James Bible ... may be carriers of the Marburg virus. This cave has been considered to be a possible source of Marburg, because two people ...
Ghana reports first cases of deadly Marburg virus. Seychelles News Agency July 18, 2022 5:07 pm ... The Marburg virus can spread from infected animals, including bats.. "The public is therefore advised to avoid caves inhabited ... Two cases of the deadly Marburg virus have been identified in Ghana, the first time the Ebola-like disease has been found in ... "This is the first time Ghana has confirmed Marburg Virus Disease," said GHS head Patrick Kuma-Aboagye said in a statement.. No ...
Protein target information for Envelope glycoprotein (Marburg virus - Musoke, Kenya, 1980). Find diseases associated with this biological target and compounds tested against it in bioassay experiments.
WHO Confirms Marburg Virus Outbreak in Equatorial Guinea, NCDC Issues Risk Assessment for Nigeria. The World Health ... A Spanish hospital has reportedly isolated a patient suspected of being infected with the lethal Marburg virus.[5] Dr Sophon ... WHO Confirms Marburg Virus Outbreak in Equatorial Guinea, NCDC Issues Risk Assessment for Nigeria. ... Direct contact can cause the transmission of the Marburg virus. The World Health Organization (WHO) noted that possible ways of ...
What are Ebola Virus Disease and Marburg Virus Disease?. Ebola Virus Disease (EVD) and Marburg Virus Disease (MVD) are both ...
Man and Woman Standing Outside of a Shell Gas Station Where Two People Became Ill with the Marburg Virus ... Health Officials Extracting a Blood Sample from a Green Monkey, Cercopithecus Aethiops, During a Marburg Virus Investigation ...
What are Ebola Virus Disease and Marburg Virus Disease?. Ebola Virus Disease (EVD) and Marburg Virus Disease (MVD) are both ...
Marburgvirus Marburg Virus Disease RNA, Viral Virus Shedding ... is a natural reservoir host for Marburg virus (MARV); however, ... Modelling filovirus maintenance in nature by experimental transmission of Marburg virus between Egyptian rousette bats. ... Modelling filovirus maintenance in nature by experimental transmission of Marburg virus between Egyptian rousette bats ... Title : Modelling filovirus maintenance in nature by experimental transmission of Marburg virus between Egyptian rousette bats ...

No FAQ available that match "marburgvirus"

No images available that match "marburgvirus"